Established risk loci for systemic lupus erythematosus at NCF2, STAT4, TNPO3, IRF5 and ITGAM associate with distinct clinical manifestations: A Danish genome-wide association study

Henrik Christian Bidstrup Leffers*, David Westergaard, Saedis Saevarsdottir, Ingileif Jonsdottir, Ole Birger Pedersen, Anne Troldborg, Anne Voss, Salome Kristensen, Jesper Lindhardsen, Prabhat Kumar, Asta Linauskas, Lars Juul, Niels Steen Krogh, Bent Deleuran, Lene Dreyer, Michael Schwinn, Lise Wegner Thørner, Lotte Hindhede, Christian Erikstrup, Henrik UllumSøren Brunak, Kari Stefansson, Karina Banasik, Søren Jacobsen, DBDS Genomic Consortium, Thomas Folkmann Hansen (Member of study group)

*Corresponding author for this work
1 Citation (Scopus)
Original languageEnglish
Article number105357
JournalJoint Bone Spine
Volume89
Issue number4
Number of pages3
ISSN1169-8446
DOIs
Publication statusPublished - Jul 2022

Keywords

  • CD11b Antigen/genetics
  • Case-Control Studies
  • Denmark/epidemiology
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Humans
  • Interferon Regulatory Factors/genetics
  • Lupus Erythematosus, Systemic/genetics
  • NADPH Oxidases
  • Polymorphism, Single Nucleotide
  • STAT4 Transcription Factor
  • beta Karyopherins
  • Systemic Lupus Erythematosus
  • GWAS
  • Genome wide association study
  • Clinical phenotype
  • SLE
  • Lupus Nephritis
  • Disease manifestations

Cite this